Polymorphism in exercise genes and respiratory function in late-onset Pompe disease.


Journal

Journal of applied physiology (Bethesda, Md. : 1985)
ISSN: 1522-1601
Titre abrégé: J Appl Physiol (1985)
Pays: United States
ID NLM: 8502536

Informations de publication

Date de publication:
01 12 2021
Historique:
pubmed: 5 11 2021
medline: 27 1 2022
entrez: 4 11 2021
Statut: ppublish

Résumé

Genetic polymorphisms influencing muscle structure and metabolism may affect the phenotype of metabolic myopathies. We here analyze the possible influence of a wide panel of "exercise genes" on the severity and progression of respiratory dysfunction in late-onset Pompe disease (LOPD). We stratified patients with comparable age and disease duration according to the severity of their respiratory phenotype, assessed by both upright FVC% and postural drop in FVC%. We included 43 patients with LOPD (25 males, age 50.8 ± 13.6 yr) with a 2-yr follow-up since the beginning of enzyme replacement therapy (ERT). Twenty-two patients showed a postural drop >25% T0, seven other patients developed it during the follow-up. We analyzed the relationship between the progression of respiratory dysfunction and genetic polymorphisms affecting muscle function and structure [angiotensin converting enzyme (ACE), α-actinin 3 (ACTN3), peroxisome proliferator-activated receptor α (PPR-α), angiotensin (AGT)], glycogen metabolism [glycogen synthase (GYS), glycogen synthase kinase-3 isoform β (GSK3β)], and autophagy [sirtuin 1 (SIRT1), autophagy-related gene 7 (ATG7)]. Individuals carrying two copies of the ACE D-allele shared a 24-fold increase in the risk of severe respiratory dysfunction and progression during the 2-yr follow-up. ACTN3-XX polymorphism was also associated with worse respiratory outcome. The study of exercise genes is of particular interest in respiratory muscles, due to their peculiar features, that is, continuous, low-intensity contraction and prominent recruitment of type I fibers. In line with previous observations on skeletal muscles, ACE-DD and ACTN3-XX genotypes were associated with indirect evidence of more severe respiratory phenotypes. On the contrary, polymorphisms related to autophagy and glycogen metabolism did not seem to influence respiratory muscles.

Identifiants

pubmed: 34734785
doi: 10.1152/japplphysiol.00154.2020
doi:

Substances chimiques

ACTN3 protein, human 0
Actinin 11003-00-2

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1762-1771

Auteurs

Sabrina Ravaglia (S)

Neurologia d'Urgenza, IRCCS Mondino Foundation, Pavia, Italy.

Alberto Malovini (A)

Riabilitazione respiratoria, Istituti Clinici Scientifici Maugeri, Pavia, Italy.

Serena Cirio (S)

Riabilitazione respiratoria, Istituti Clinici Scientifici Maugeri, Pavia, Italy.

Cesare Danesino (C)

Dipartimento di Medicina Molecolare, Unità di Biologia Generale e Genetica Medica, Università di Pavia, Pavia, Italy.

Paola De Filippi (P)

Dipartimento di Medicina Molecolare, Unità di Biologia Generale e Genetica Medica, Università di Pavia, Pavia, Italy.

Maurizio Moggio (M)

UO Malattie Neuromuscolari e Rare, IRCCS Ca' Granda Ospedale Maggiore Policlinico Milano, Centro Dino Ferrari Univ Studi Milano, Milan, Italy.

Tiziana Mongini (T)

Neuromuscular Unit, Department of Neurosciences RLM, University of Torino, Torino, Italy.

Lorenzo Maggi (L)

Neuroimmunology and Neuromuscular Diseases Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.

Serena Servidei (S)

Istituto di Neurologia, Università Cattolica Policlinico Gemelli, Rome, Italy.

Andrea Vianello (A)

Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova, Padova, Italy.

Antonio Toscano (A)

Department of Clinical and Experimental Medicine, UOC Neurologia e Malattie Neuromuscolari, University of Messina, Messina, Italy.

Paola Tonin (P)

Department of Neurosciences, Biomedicine and Movement Sciences, Section of Clinical Neurology, University of Verona, Verona, Italy.

Maria Antonietta Maioli (MA)

Centro Sclerosi Multipla, P.O. Binaghi, ASSL Cagliari, Cagliari, Italy.

Rossella Parini (R)

Fondazione MBBM presso Ospedale San Gerardo, Monza, Italy.

Massimiliano Filosto (M)

Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
NeMO-Brescia Clinical Center for Neuromuscular Diseases, Brescia, Italy.

Grazia Crescimanno (G)

Regional Center for Prevention and Treatment of Respiratory Complications of Rare Genetic Neuromuscular Diseases, Villa Sofia-Cervello Hospital, Palermo, Italy.

Sebastiano Arceri (S)

Neurologia d'Urgenza, IRCCS Mondino Foundation, Pavia, Italy.

Manuela Piran (M)

Riabilitazione respiratoria, Istituti Clinici Scientifici Maugeri, Pavia, Italy.

Annalisa Carlucci (A)

Riabilitazione respiratoria, Istituti Clinici Scientifici Maugeri, Pavia, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH